# Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.

- **DOI:** [10.1212/wnl.0000000000214804](https://doi.org/10.1212/wnl.0000000000214804)
- **Rating:** Limited (2.6 out of 5)
- **Verdict:** A useful DIAD reserve analysis extends resilience research into presymptomatic disease, but concurrent residual measurement and unsupported progression claims constrain its conclusions.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1212%2Fwnl.0000000000214804

## Key claims

1. higher cognitive reserve values are associated with delayed conversion to mild cognitive impairment and slower progression on clinical dementia rating scales
   - Support: Tentative
   - Type: Primary finding
   - Basis: post-onset CogR was non-significant, while concurrent residual measurement cannot establish delayed conversion
   - Location: Discussion, paragraph 1
2. A 1 SD increase in the reserve component (CogR) was associated with a 4.06-fold increase in the odds of being clinically unimpaired
   - Support: Supported
   - Type: Secondary
   - Basis: association direction is consistent, although the body reports a different estimate and the analysis is cross-sectional
   - Location: Abstract, Results
3. MC demonstrated a significantly steeper decline, suggesting a depletion of reserve mechanisms as the disease progresses
   - Support: Supported
   - Type: Secondary
   - Basis: piecewise longitudinal modeling supports the observed CogR decline, but depletion remains a mechanistic interpretation
   - Location: Results, “Longitudinal Changes in Cognitive Reserve”

## Strengths

- **Distinctive presymptomatic DIAD study setting** Known familial variants and estimated years from onset allow reserve patterns to be examined before and around expected symptom onset, with related noncarriers providing a familial reference for longitudinal CogR trajectories.
  - Dimension: contribution
  - Location: Introduction paragraphs 3 and 5; Methods, Statistical Analysis
- **Structured multimodal reserve decomposition** The SEM separates demographic, biomarker, and residual cognitive components using cognitive, imaging, CSF, and demographic measures rather than relying solely on education or occupation proxies.
  - Dimension: methodological rigour
  - Location: Methods, Measures of Reserve; Figure 1
- **Relevant engagement with contrasting literature** The Discussion compares the DIAD findings with reports of faster post-onset decline among higher-reserve groups in sporadic AD and identifies harmonized replication as a next step.
  - Dimension: positioning
  - Location: Discussion paragraphs 5–6

## Limitations

- **Central results are internally inconsistent** The Abstract and Results report different CogR, CogD, and CogB estimates, with CogD significant in the Abstract but null in Results. The Abstract also names Cox models not described in Statistical Analysis.
  - Dimension: reporting
  - Location: Abstract; Methods, Statistical Analysis; Results, Table 2
- **Progression claim exceeds reported evidence** After symptom onset, Results states that only CogB is significant and describes the high-CogR progression difference as non-significant. The Discussion nevertheless concludes that reserve decelerates post-onset decline.
  - Dimension: methodological rigour
  - Location: Results, Table 3 and “Cognitive Reserve Modifies the Expected Age at Symptom Onset”; Discussion paragraph 1
- **Reserve construction limits temporal inference** Baseline CogR is estimated from a cognitive composite measured alongside CDR-SB, so residual cognition may reflect concurrent impairment, measurement overlap, or unmeasured pathology rather than antecedent reserve. Mean follow-up was approximately 2.24 years.
  - Dimension: methodological rigour
  - Location: Methods, Measures of Reserve and Statistical Analysis; Results, opening paragraph

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - A 1 SD increase in the reserve component (CogR) was associated with a 4.06-fold increase in the odds of being clinically unimpaired: "a 1 SD increase in the reserve component (CogR) was associated with a 4.06-fold increase in the odds of being clinically unimpaired (CDR-SB = 0; 95% CI 1.84-8.95)." (Abstract, Results) vs "1 SD increase in the reserve component would multiply the odds of being CDR-SB = 0 by 3.66 (95% CI 2.11–6.38)" (Results, Cognitive Reserve, Clinical Status, and Disease Progression, paragraph 1). The Abstract reports an odds ratio of 4.06 with CI 1.84–8.95, whereas the Results report 3.66 with CI 2.11–6.38 for the same baseline CogR association; both intervals exclude 1. → Conclusion holds
  - higher cognitive reserve values are associated with delayed conversion to mild cognitive impairment and slower progression on clinical dementia rating scales: "However, after symptom onset, the demographic component's effect diminishes, with only the reserve (CogR) and biomarker (CogB) components remaining significantly associated with disease progression." (Discussion, paragraph 4) vs "After symptom onset, all components were associated with lower CDR-SB (Table 3), while only CogB is significant." (Results, Cognitive Reserve, Clinical Status, and Disease Progression, paragraph 2). The Discussion explicitly identifies CogR as significantly associated with post-onset progression, whereas the longitudinal Results identify only CogB as significant and separately describe the high-CogR post-onset progression comparison as not statistically significant. → Not supported by the paper's own data
  - Minor reporting notes (3):
    - Descriptive: "Similarly, a 1 SD increase in the demographic (CogD) and biomarker (CogB) components increased the odds of being CDR-SB = 0 by 2.60 (95% CI 1.10-6.16) and 5.16 (95% CI 2.00-13.33), respectively." (Abstract, Results) vs "1 SD increase in demographic component and biomarker component will multiple the odds by 1.24 (95% CI 0.76–2.02) and 7.77 (95% CI 3.40–17.80), respectively (Table 2)." (Results, Cognitive Reserve, Clinical Status, and Disease Progression, paragraph 1). For baseline CogD, replacing the Abstract's OR 2.60 and CI 1.10–6.16 with the Results' OR 1.24 and CI 0.76–2.02 changes the interval from excluding to including the null odds ratio of 1. → Loses significance
    - Descriptive: "Similarly, a 1 SD increase in the demographic (CogD) and biomarker (CogB) components increased the odds of being CDR-SB = 0 by 2.60 (95% CI 1.10-6.16) and 5.16 (95% CI 2.00-13.33), respectively." (Abstract, Results) vs "1 SD increase in demographic component and biomarker component will multiple the odds by 1.24 (95% CI 0.76–2.02) and 7.77 (95% CI 3.40–17.80), respectively (Table 2)." (Results, Cognitive Reserve, Clinical Status, and Disease Progression, paragraph 1). For baseline CogB, the Abstract reports OR 5.16 with CI 2.00–13.33 and the Results report OR 7.77 with CI 3.40–17.80, but both intervals remain above 1. → Conclusion holds
    - Descriptive: "A 1 SD increase in CogR was associated with a 0.81-fold reduction in baseline CDR-SB score (95% CI 0.72-0.92), and a 1 SD increase in CogB was associated with a 0.60-fold reduction in CDR-SB (95% CI 0.50-0.71)." (Abstract, Results) vs "One SD increase in reserve and in biomarker corresponds to a 0.83-fold (95% CI 0.75–0.92) and 0.60-fold (95% CI 0.52–0.69) decrease in baseline CDR-SB, respectively (Table 2)." (Results, Cognitive Reserve, Clinical Status, and Disease Progression, paragraph 1). The symptomatic baseline CogR estimate changes from 0.81 to 0.83 and both components' confidence intervals differ between Abstract and Results, but every interval remains below the null ratio of 1. → Conclusion holds
- **Reporting and transparency:** Noted. The Abstract names a Cox analysis that is not presented in the body, and the reserve-model biomarker definition names pTau217 while the assay description names p-tau181. Neither reporting mismatch permits a corrected clinical effect estimate from the supplied text.
  - Conflict of interest: not stated · Ethics approval: declared · Preregistration: declared · Data availability: declared · Code availability: declared
- **Reference integrity:** Clean
  - 48 references in manuscript
  - 46 of 46 checkable references found in an index
  - 2 have no canonical index record — counted, but not index-checkable
  - 1 reference confirmed by manual review
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
